Patents Examined by Ralph Gitomer
  • Patent number: 9539293
    Abstract: Described herein are porcine lactic acid bacterial strain compositions and processes of obtaining porcine lactic acid bacterial strains. Further aspects of the invention relate to food additives, supplements and probiotic compositions comprising said bacterial strains, and therapeutic uses of said bacterial strain compositions.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: January 10, 2017
    Assignee: 4D Pharma Research Limited
    Inventor: Denise Kelly
  • Patent number: 9534261
    Abstract: There is provided a process for effecting growth of phototrophic biomass within the reaction zone of a photobioreactor, comprising, after effecting at least a reduction in the molar rate of supply of carbon dioxide to the reaction zone of the photobioreactor, supplying a gaseous photobioreactor exhaust, that includes diatomic (or molecular) oxygen being generated by photosynthesis effected within the reaction zone by the supplied carbon dioxide, to a combustion zone of a combustor.
    Type: Grant
    Filed: October 24, 2012
    Date of Patent: January 3, 2017
    Assignee: Pond Biofuels Inc.
    Inventors: Jaime A. Gonzalez, Max Kolesnik, Steven C. Martin
  • Patent number: 9533258
    Abstract: A formulation and process for capturing CO2 use an absorption mixture containing water, biocatalysts and a carbonate compound. The process includes contacting a CO2-containing gas with the absorption mixture to enable dissolution and transformation of CO2 into bicarbonate and hydrogen ions, thereby producing a CO2-depleted gas and an ion-rich solution, followed by subjecting the ion-rich solution to desorption. The biocatalyst improves absorption of the mixture comprising carbonate compounds and the carbonate compound promotes release of the bicarbonate ions from the ion-rich solution during desorption, producing a CO2 gas stream and an ion-depleted solution.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: January 3, 2017
    Assignee: C02 SOLUTIONS INC.
    Inventors: Sylvie Fradette, Julie Gingras, Jonathan Carley, Glenn R. Kelly, Olivera Ceperkovic
  • Patent number: 9518972
    Abstract: The invention is directed to methods of detecting lung, gastrointestinal tract, and systemic infections by measuring 13CO2/12CO2 isotopic ratios of gaseous carbon dioxide in exhaled breath samples of a subject after administration of a 13C-isotopically-labeled compound.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: December 13, 2016
    Assignees: Avisa Pharma, Inc., Southwest Sciences, Inc.
    Inventors: David S. Joseph, Steven M. Massick, Kristen A. Peterson, Anthony L. Gomez, Joel A. Silver
  • Patent number: 9516875
    Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.
    Type: Grant
    Filed: February 12, 2013
    Date of Patent: December 13, 2016
    Assignee: TRANSMEDICS, INC.
    Inventors: Robert Fishman, Robert Havener, Ihab A. Fattah, Anas Abdelazim, Scott Newell, Thomas H. Bishop, Tamer I. Khayal, Stanley Kyi, Ron Taylor, Jr., Doug Harriott, Matthew De Remer, Paul Murray, John Sullivan, Mark Anderson, Richard Bringham, Michael Van Driel, Waleed H. Hassanein
  • Patent number: 9512462
    Abstract: A method for detecting the presence or absence of an antibiotic resistant pathogenic staphylococci in a test sample is provided. The method includes the steps of: a) providing a test medium having at least one hydrolysable substrate, which substrate is operable to promote the growth of the antibiotic resistant pathogenic staphylococci and to produce a detectable signal when the hydrolyzable substrate is metabolized by the antibiotic resistant pathogenic staphylococci; b) forming a mixture of the test sample and hydrated test medium; c) incubating the mixture at temperatures in the range of about 20° C. to about 35° C.; and d) detecting the presence or absence of the antibiotic resistant pathogenic staphylococci in the test sample by the presence or absence of the detectable signal in the mixture.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: December 6, 2016
    Assignee: Pilots Point LLC
    Inventor: Stephen C. Edberg
  • Patent number: 9513253
    Abstract: Droplet actuators and techniques for droplet-based assays are provided. A method of conducting an assay comprises: incubating a droplet in oil, the droplet comprising an umbelliferone substrate, a sample potentially comprising an enzyme which cleaves the umbelliferone substrate, and a zwitterionic surfactant; and detecting a signal emitted from the droplet.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: December 6, 2016
    Assignee: Advanced Liquid Logic, Inc.
    Inventor: Theodore Winger
  • Patent number: 9511094
    Abstract: Cells present in adipose tissue are used to stroke and stroke related diseases and disorders in a patient. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the regenerative cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, cells present in adipose tissue are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic benefit.
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: December 6, 2016
    Assignee: Cytori Therapeutics, Inc.
    Inventors: John K. Fraser, Marc H. Hedrick, Brian M. Strem
  • Patent number: 9512463
    Abstract: Methods and liquid compositions for assaying the activity of one or more lysosomal enzymes in a sample are provided. In some embodiments, the assay is a multiplexed assay for the activities of a plurality of lysosomal enzymes in the sample. The compositions and methods can comprise or employ: one or more metal cations effective for precipitating sulfate ions, one or more metal cations effective for precipitating phosphate ions, a maltase glucoamylase inhibitor, a beta-N-acetylhexosaminidase inhibitor, and one or more surfactants.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: December 6, 2016
    Assignee: University of Washington
    Inventors: Michael H. Gelb, Frantisek Turecek, Zdenek Spacil, C. Ronald Scott, Mariana Natali Barcenas Rodriguez
  • Patent number: 9506928
    Abstract: Provided herein are methods, compounds, mixtures and formulations of antigen retrieval agent useful in retrieving antigens and improving the detection of amino acids, peptides and proteins or epitopes thereon in a tissue fixed with aldehyde-based cross-linking agents. Contacting the fixed tissue with a solution of the aldehyde scavenging agent causes reactivity with the aldehyde moieties to retrieve antigens and improve detection of the amino acids, peptides and proteins or epitopes. Also provided are kits comprising the antigen retrieval agent and, optionally, components for staining or detecting the proteins or the antigens or epitopes and instructions for using the kit. Further provided is a method for identifying an antigen retrieval agent. A fixed protein is contacted with an agent to be tested and heated in solution therewith. Detection of protein peaks via mass spectrometry indicates the tested agent is an antigen retrieval agent.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: November 29, 2016
    Assignee: UNIVERSITY OF HOUSTON SYSTEM
    Inventors: Jason Eriksen, Craig Vollert, Steven Bark, Wilna Moree
  • Patent number: 9499794
    Abstract: The present disclosure describes methods of maintaining the phenotype of differentiated cells. Generally, the natural environment of the body is replicated for the differentiated cell. The differentiated cell is plated on a cell culture substrate comprising a laminin, such as laminin-521 or laminin-511. The substrate may also contain a cadherin. This maintains the phenotype of the differentiated cell.
    Type: Grant
    Filed: April 19, 2013
    Date of Patent: November 22, 2016
    Assignee: BioLamina AB
    Inventors: Karl Tryggvason, Karl Kristian Tryggvason, Anna Domogatskaya
  • Patent number: 9499843
    Abstract: The invention relates to a micro-organism comprising a hydrogenase enzyme system which is capable of converting carbon dioxide into formic acid and a second enzyme system which is capable of converting formic acid into aliphatic carboxylic acids having a chain length of five or more carbon atoms. Also described are various methods for producing oil, as well as other aspects of the invention.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: November 22, 2016
    Assignee: VERDANT BIOPRODUCTS LIMITED
    Inventor: Irene Finnegan
  • Patent number: 9498500
    Abstract: Methods of washing adherent cells, capable of effectively suppressing cell death due to proteolytic enzyme treatment for detaching the adherent cell from a culture vessel and subsequent cell treatment; cell-washing solutions used for the washing method; methods of producing cell suspensions for transplantation using the cell-washing solution; and kits comprising the cell-washing solution. Trehalose or its derivative or a salt thereof is added to physiological aqueous solutions to prepare cell-washing solutions containing trehalose or its derivative or a salt thereof as an active ingredient. The cell-washing solutions can be used to wash adherent cells before detaching the adherent cells from a culture vessel by proteolytic enzyme treatment to suppress cell death due to the proteolytic enzyme treatment. The concentration of trehalose applied to the cell-washing solution may be a concentration capable of suppressing the cell death due to the proteolytic enzyme treatment, such as 0.1 to 20 (w/v) %.
    Type: Grant
    Filed: April 21, 2015
    Date of Patent: November 22, 2016
    Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Eiji Kobayashi, Tamaki Wada, Masako Doi
  • Patent number: 9492515
    Abstract: Described herein are compositions which include digestive enzymes and which are formulated to reduce one or more symptoms of a neuropsychiatric disorder. Also described herein is a method for treating an individual with a neuropsychiatric disorder using digestive enzymes and their derivatives to alleviate the symptoms of neuropsychiatric disorders. The method comprises administering to the individual an effective amount of digestive enzymes that are either naturally or recombinantly derived, or their derivatives, in an amount effective to reduce one or more symptoms of the neuropsychiatric disorder.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: November 15, 2016
    Assignee: CUREMARK, LLC
    Inventors: Joan M. Fallon, Matthew Heil, James Szigethy, James Fallon
  • Patent number: 9492473
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: November 15, 2016
    Assignee: KALEIDO BIOSCIENCES, INC.
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia
  • Patent number: 9488651
    Abstract: The invention generally relates to methods of measuring cleaved von Willebrand factor (VWF) fragments. More specifically, the invention relates to methods of measuring the ability of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) to cleave VWF in vivo. The invention also relates to methods of using various animal models which demonstrate ADAMTS13 activity similar to that of a human. The invention further relates to methods of measuring the cleavage products of rVWF in mammals, particularly in humans and in human plasma.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: November 8, 2016
    Assignees: BAXALTA INCORPORATED, BAXALTA GMBH
    Inventors: Katalin Varadi, Hanspeter Rottensteiner, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner
  • Patent number: 9488644
    Abstract: An in vitro assay is provided for determining the effect of an immune cell on a cell from an infectious or neoplastic disease. Also provided is an in vitro assay for determining the effect of an activated CD8+ T-cell on a sensitized melanoma cell. A method for improving the specific cytolytic activity (SCA) of an immune cell comprising contacting an immune cell with an antigen and an antigen-independent pro-inflammatory agent is provided. A method for ex vivo expansion of antigen-specific CD8+ T-cells with enhanced specific cytolytic activity (SCA) comprising culturing the antigen-specific CD8+ T-cells in a suitable culture media comprising an amino acid. An in vitro assay is provided for determining the effect of an immune cell on a cell from an infectious or neoplastic disease. A method of treating a subject suffering from an infectious or neoplastic disease with immuno therapy is described.
    Type: Grant
    Filed: November 11, 2010
    Date of Patent: November 8, 2016
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Samuel C. Silverstein, John D. Loike, Sadna Budhu, Peter P. Lee
  • Patent number: 9474773
    Abstract: Isolated Lactobacillus strains are useful in preventing or delaying the development of Type 1 Diabetes (T1D). A probiotic composition comprising the Lactobacillus strains and use of the composition in T1D prevention are provided.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: October 25, 2016
    Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Josef Neu, Graciela Liliana Lorca, Eric W. Triplett, Mark A. Atkinson, Desmond A. Schatz
  • Patent number: 9476084
    Abstract: This disclosure provides methods for enumeration of microorganisms within a freeze-dried powder suspected of containing Lactobacilli or Bifidobacteria.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: October 25, 2016
    Assignee: MAK WOOD, INC.
    Inventors: Mark A. Brudnak, Eric J. Baer
  • Patent number: 9469879
    Abstract: A method for differentiating forms of lymphoma involves analyzing a tumor tissue sample from a subject for expression of CD28, ABCA5, CCDC3, and SMOC2. The CD28:ABCA5 expression ratio differentiates T-cell tumors from B-cell tumors. The CCDC3:SMOC2 expression ratio differentiates different T-cell tumors. The method can further include administering to the subject from whom the sample was obtained an appropriate treatment for the form lymphoma identified by performing the method.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: October 18, 2016
    Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Jaime Freddy Modiano, Aric Mathew Frantz, Timothy David O'Brien, Aaron Lyman Sarver